Spencer Wilson, MD
Gastroenterology · Indianapolis, INNPI 1679731046
Payments from drug & device makers
Across 711 payments — averaging $17.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Johnson & Johnson$782
- Bristol Myers Squibb$559
- Pfizer$465
- plus $3K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 202 | $4,127 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 123 | $2,127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 90 | $1,390 |
| Johnson & Johnson | 51 | $782 |
| Bristol Myers Squibb | 44 | $559 |
| Pfizer | 33 | $465 |
| Ironwood Pharmaceuticals, Inc | 18 | $296 |
| Nestle Healthcare Nutrition Inc. | 15 | $237 |
| Regeneron Healthcare Solutions, Inc. | 13 | $221 |
| Gilead | 12 | $194 |
| Ardelyx, Inc. | 10 | $168 |
| Redhill Biopharma Inc. | 8 | $141 |
| Braintree Laboratories, Inc. | 8 | $138 |
| Celltrion USA Inc. | 8 | $138 |
| Sanofi | 5 | $132 |
| Romark Laboratories, LC | 6 | $120 |
| Phathom Pharmaceuticals, Inc. | 7 | $119 |
| Daiichi Sankyo Inc. | 8 | $114 |
| Ferring Pharmaceuticals Inc. | 7 | $106 |
| Ipsen Biopharmaceuticals, Inc | 5 | $104 |
| Madrigal Pharmaceuticals | 4 | $91 |
| Aimmune Therapeutics, Inc. | 4 | $88 |
| UCB, Inc. | 6 | $82 |
| Sandoz | 4 | $68 |
| Lilly USA, LLC | 2 | $45 |
| Intercept Pharmaceuticals, Inc. | 3 | $44 |
| Boston Scientific | 1 | $35 |
| Medtronic | 2 | $34 |
| Mauna Kea Technologies, Inc. | 1 | $33 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Concordia Pharmaceuticals Inc. | 2 | $25 |
| Novo Nordisk | 1 | $24 |
| Axonics, Inc. | 1 | $19 |
| Vivus LLC | 1 | $17 |
| Amgen | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Organon | 1 | $14 |
| AstraZeneca | 1 | $11 |
How this compares
$12,374 in reported general payments places this provider in the 80th percentile of 323 gastroenterology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gastroenterology in Indianapolis
- Monika FischerIndianapolis$2.8M
- Douglas RexIndianapolis$2.3M
- David PoundIndianapolis$1.4M
- Naga ChalasaniIndianapolis$1.1M
- Marwan GhabrilIndianapolis$464K
- Ajay JainIndianapolis$432K
- Mark GromskiIndianapolis$408K
- John WoIndianapolis$334K
- Paul HaynesIndianapolis$308K
- Craig LammertIndianapolis$239K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.